140 related articles for article (PubMed ID: 8418163)
1. In vitro inhibition of Borrelia burgdorferi growth by antibodies.
Sadziene A; Thompson PA; Barbour AG
J Infect Dis; 1993 Jan; 167(1):165-72. PubMed ID: 8418163
[TBL] [Abstract][Full Text] [Related]
2. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.
Sambri V; Armati S; Cevenini R
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):67-71. PubMed ID: 8364524
[TBL] [Abstract][Full Text] [Related]
3. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.
Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG
Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309
[TBL] [Abstract][Full Text] [Related]
4. Antiborrelial activity of serum from rats injected with the Lyme disease spirochete.
Pavia CS; Kissel V; Bittker S; Cabello F; Levine S
J Infect Dis; 1991 Mar; 163(3):656-9. PubMed ID: 1995740
[TBL] [Abstract][Full Text] [Related]
5. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.
Coleman JL; Rogers RC; Benach JL
Infect Immun; 1992 Aug; 60(8):3098-104. PubMed ID: 1639477
[TBL] [Abstract][Full Text] [Related]
6. The complement-killing of Borrelia burgdorferi. Target antigens and sensitizing antibodies.
Cacciapuoti B; Ciarrocchi S; Ciceroni L
Zentralbl Bakteriol; 1998 Jul; 288(1):121-9. PubMed ID: 9728412
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi.
Cevenini R; Sambri V; Massaria F; La Placa M; Brocchi E; De Simone F
FEMS Microbiol Lett; 1992 Jan; 69(2):147-52. PubMed ID: 1537543
[TBL] [Abstract][Full Text] [Related]
8. A murine IgG1 monoclonal antibody that binds specifically to outer surface protein A of Lyme disease spirochete Borrelia burgdorferi.
Abolhassani M; Pavia CS; Dunn JJ; Chiao JW
FEMS Microbiol Lett; 1993 May; 109(2-3):303-9. PubMed ID: 8339920
[TBL] [Abstract][Full Text] [Related]
9. Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance.
Güner ES
Experientia; 1996 Apr; 52(4):364-72. PubMed ID: 8620942
[TBL] [Abstract][Full Text] [Related]
10. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.
Sădziene A; Rosa PA; Thompson PA; Hogan DM; Barbour AG
J Exp Med; 1992 Sep; 176(3):799-809. PubMed ID: 1339462
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection.
Schaible UE; Wallich R; Kramer MD; Museteanu C; Simon MM
Behring Inst Mitt; 1991 Feb; (88):59-67. PubMed ID: 2049047
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
15. Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.
Kochi SK; Johnson RC; Dalmasso AP
Infect Immun; 1993 Jun; 61(6):2532-6. PubMed ID: 8500889
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
Benach JL
Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
[TBL] [Abstract][Full Text] [Related]
17. [Growth inhibition of Borrelia burgdorferi sensu lato by antibodies. A contribution to understanding the pathogenesis and improving diagnosis of Lyme borreliosis].
Sadziene A; Barbour AG
Wien Med Wochenschr; 1995; 145(7-8):162-5. PubMed ID: 7610664
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer.
Nelson DR; Rooney S; Miller NJ; Mather TN
J Parasitol; 2000 Dec; 86(6):1232-8. PubMed ID: 11191897
[TBL] [Abstract][Full Text] [Related]
19. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
Luke CJ; Carner K; Liang X; Barbour AG
J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion by tickborne and host-adapted Borrelia burgdorferi.
de Silva AM; Fikrig E; Hodzic E; Kantor FS; Telford SR; Barthold SW
J Infect Dis; 1998 Feb; 177(2):395-400. PubMed ID: 9466527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
